Filing Flows › 8-K events › Enhanced Group
Enhanced Group: entry into a material definitive agreement
Form 8-K filed Nov 5, 2026 · items 1.01, 3.02, 5.07, 7.01
Share offeringsEnhanced Group (NYSE: ENHA) to Acquire Controlling Interest in Pan-European Live Entertainment Company DEAG, Creating a Global Platform for the Experience Economy, And Conducting Concurrent $15 Millio
What the filing says
On November 4, 2026, Enhanced Group Inc., a Texas corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with the investors identified therein (each, an “Investor” and, together, the “Investors”), pursuant to which the Company agreed to issue and sell in a private placement
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 3.02: +0.1% next session across 2,750. Item 5.07: 0.0% next session across 16,815. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Enhanced Group at a glance
Enhanced Group, Q2 2026: revenue $17.7M, operating margin -349.8%. The chart follows the revenue to costs, profit and cash.
Enhanced Group: every quarter, Q/Q and Y/Y, holders and guidance →
Enhanced Group’s other material 8-Ks
Other recent share offerings
- Airsculpt Technologies Nov 6, 2026
- Biovie Nov 6, 2026
- Clean Energy Technologies Nov 6, 2026
- Nextnrg Nov 6, 2026
- Paid Nov 6, 2026
- Silo Pharma Nov 6, 2026
- Agility Robotics Nov 6, 2026
- American Healthcare REIT Nov 6, 2026
- Entera Bio Nov 6, 2026
- Janus Living Nov 6, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.